Combined blockade of AT(2) and AT((1-7)) receptors significantly increased the blood pressure of losartan-treated salt-depleted spontaneously hypertensive rats by 15 ± 1 mmHg (P < 0.01).
In salt-depleted spontaneously hypertensive rats, ANG II and ANG-(1-7) act through non-AT1 receptors to oppose the vasoconstrictor actions of ANG II.
Mean Difference: 15
p-value: p=<0.01
This study evaluated the contribution of angiotensin peptides acting at various receptor subtypes to the arterial pressure and heart rate of adult 9-wk-old male conscious salt-depleted spontaneously hypertensive rats (SHR). Plasma ANG II and ANG I in salt-depleted SHR were elevated sevenfold compared with peptide levels measured in sodium-replete SHR, whereas plasma ANG-(1-7) was twofold greater in salt-depleted SHR compared with salt-replete SHR. Losartan (32.5 micromol/kg), PD-123319 (0.12 micromol. kg(-1). min(-1)), d-Ala(7)ANG-(1-7) (10 and 100 pmol/min), and a polyclonal ANG II antibody (0.08 mg/min) were infused intravenously alone or in combination. Combined blockade of AT(2) and AT((1-7)) receptors significantly increased the blood pressure of losartan-treated SHR (+15 +/- 1 mmHg; P < 0.01); this change did not differ from the blood pressure elevation produced by the sole blockade of AT((1-7)) receptors (15 +/- 4 mmHg). On the other hand, sole blockade of AT(2) receptors in losartan-treated SHR increased mean arterial pressure by 8 +/- 1 mmHg (P < 0.05 vs. 5% dextrose in water as vehicle), and this increase was less than the pressor response produced by blockade of AT((1-7)) receptors alone or combined blockade of AT((1-7)) and AT(2) receptors. The ANG II antibody increased blood pressure to the greatest extent in salt-depleted SHR pretreated with only losartan (+11 +/- 2 mmHg) and to the least extent in salt-depleted SHR previously treated with the combination of losartan, PD-123319, and d-Ala(7)ANG-(1-7) (+7 +/- 1 mmHg; P < 0.01). Losartan significantly increased heart rate, whereas other combinations of receptor antagonists or the ANG II antibody did not alter heart rate. Our results demonstrate that ANG II and ANG-(1-7) act through non-AT(1) receptors to oppose the vasoconstrictor actions of ANG II in salt-depleted SHR. Combined blockade of AT(2) and AT((1-7)) receptors and ANG II neutralization by the ANG II antibody reversed as much as 67% of the blood pressure-lowering effect of losartan.
Nakamura et al. (Wed,) conducted a other in Salt-depleted spontaneously hypertensive rats (SHR). Combined blockade of AT(2) and AT((1-7)) receptors (Losartan, PD-123319, [d-Ala(7)]ANG-(1-7)) vs. 5% dextrose in water as vehicle was evaluated on Blood pressure (MD +15 mmHg, p=<0.01). Combined blockade of AT(2) and AT((1-7)) receptors significantly increased the blood pressure of losartan-treated salt-depleted spontaneously hypertensive rats by 15 ± 1 mmHg (P < 0.01).